Sensyne Health (LSE:SENS)
Historical Stock Chart
3 Months : From Nov 2019 to Feb 2020
By Ian Walker
Sensyne Health PLC (SENS.LN) said Monday that it has agreed to a research project with Roche Holding AG (RO.EB) to apply artificial intelligence for clinical trial design.
The British clinical AI technology company said the project will initially focus on identifying patient populations in one disease area and assessing and collating anonymized patient data with anonymized electronic patient record information to support clinical trial planning.
No financial terms were disclosed.
Write to Ian Walker at email@example.com
(END) Dow Jones Newswires
December 23, 2019 05:16 ET (10:16 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.